We also previously identified that the MAD2 regulatory microRNA miR-433 was dysregulated and associated with poor prognosis in ovarian cancer patients and may act as an upstream inducer of MAD2 mediated senescence [11]. Here, MAD2L1 is linked to ovarian carcinoma.